Worse Outcomes of Hysterectomy by Very Low-Volume Surgeons
Complications, including death, are more common after hysterectomies performed by surgeons who do only one such procedure per year, researchers report. Reuters Health Information …read more
Complications, including death, are more common after hysterectomies performed by surgeons who do only one such procedure per year, researchers report. Reuters Health Information …read more
Pot during pregnancy? More than two thirds of cannabis dispensaries in Colorado recommended it for nausea relief during the first trimester, a new study has found. Medscape Medical News …read more
Women do not have a prostate in the same way as men. They do, however, have Skene glands, often called the female prostate, which have many similarities to the prostate. Cancer of the female prostate is extremely rare. Find out about the functions of the Skene glands and learn more about female prostate cancer here.…
A major 24-year-long study finds that lesbian and bisexual women tend to develop type 2 diabetes at a much higher rate than heterosexual women. …read more
Previous research has suggested that women with epilepsy have lower fertility and fewer live births than do women in the general population. This study shows that fertility, time to conception, and the number of live births are similar. Medscape Medical News …read more
One of the genes that regulate our circadian rhythm might also contribute to the normal development of mammary glands and protect against breast cancer. …read more
Although absolute rates of adverse outcomes are low, attempted vaginal birth after cesarean (VBAC) delivery is associated with higher relative rates of morbidity and mortality in mothers and infants, researchers say. Reuters Health Information …read more
Individuals with familial hypercholesterolemia could eventually be diagnosed at birth via their umbilical cord blood, allowing treatment to start years before symptoms develop, say Danish researchers. Medscape Medical News …read more
A new study unlocks the mystery of ovarian cancer metastasis. The findings may lead to new treatments, using existing drugs to stop tumors from spreading. …read more
The FDA has approved mirabegron (Myrbetriq, Astellas Pharma) in combination with solifenacin succinate for the treatment of overactive bladder (OAB). FDA Approvals …read more